New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
07:40 EDTESRX, INSYInsys valuation could be $4 lower on Subsys exclusion, says Wells Fargo
After another research firm stated that Insys' (INSY) Subsys would be placed on Express Scripts' (ESRX) list of excluded drugs, Wells Fargo estimates that such a development could reduce Insys' valuation by about $4. The firm notes that the stock fell $4.16 on July 31 and August 1. It keeps an Outperform rating on the shares.
News For INSY;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
11:26 EDTESRXBMO Capital specialty pharma analyst holds analyst/industry conference call
Subscribe for More Information
March 30, 2015
10:59 EDTESRXUnitedHealth in 'ring' with largest competitors after deal, say Piper Jaffray
Subscribe for More Information
March 26, 2015
07:30 EDTINSYDeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 25, 2015
16:37 EDTESRXSpecialists On Call names Hammad Shah as CEO
Subscribe for More Information
11:45 EDTESRXLeerink healthcare tech/pharma analysts hold analyst/industry conference call
Subscribe for More Information
March 23, 2015
10:31 EDTINSYInsys Therapeutics management to meet with JMP Securities
Subscribe for More Information
March 17, 2015
08:04 EDTESRXExpress Scripts has a conference call hosted by JPMorgan
JPMorgan Analyst Gill will host a conference call with CEO George Paz on March 18 at 11 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use